Front Barnett Associates Lowers stake in Walgreens Boots Alliance Inc (WBA)

Walgreens Boots Alliance Inc (WBA) : Front Barnett Associates reduced its stake in Walgreens Boots Alliance Inc by 1.95% during the most recent quarter end. The investment management company now holds a total of 204,549 shares of Walgreens Boots Alliance Inc which is valued at $16,282,100 after selling 4,063 shares in Walgreens Boots Alliance Inc , the firm said in a disclosure report filed with the SEC on Aug 3, 2016.Walgreens Boots Alliance Inc makes up approximately 3.19% of Front Barnett Associates’s portfolio.

Other Hedge Funds, Including , Ballentine Partners reduced its stake in WBA by selling 1,421 shares or 18.52% in the most recent quarter. The Hedge Fund company now holds 6,251 shares of WBA which is valued at $497,580. Walgreens Boots Alliance Inc makes up approx 0.04% of Ballentine Partners’s portfolio.Eads Heald Investment Counsel reduced its stake in WBA by selling 284 shares or 1.33% in the most recent quarter. The Hedge Fund company now holds 21,095 shares of WBA which is valued at $1,671,779. Walgreens Boots Alliance Inc makes up approx 1.13% of Eads Heald Investment Counsel’s portfolio.Smith Salley Associates reduced its stake in WBA by selling 1,459 shares or 6.82% in the most recent quarter. The Hedge Fund company now holds 19,923 shares of WBA which is valued at $1,578,898. Walgreens Boots Alliance Inc makes up approx 0.35% of Smith Salley Associates’s portfolio. Newsquare Capital added WBA to its portfolio by purchasing 248 company shares during the most recent quarter which is valued at $19,825.

Walgreens Boots Alliance Inc opened for trading at $80.42 and hit $80.8 on the upside on Monday, eventually ending the session at $80.63, with a gain of 0.12% or 0.1 points. The heightened volatility saw the trading volume jump to 38,65,534 shares. Company has a market cap of $87,267 M.

On the company’s financial health, Walgreens Boots Alliance Inc reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 6, 2016. Analyst had a consensus of $1.14. The company had revenue of $29498.00 million for the quarter, compared to analysts expectations of $29719.29 million. The company’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.02 EPS.

Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Shares were Reiterated by FBR Capital on Jul 7, 2016 to “Mkt Perform” and Lowered the Price Target to $ 85 from a previous price target of $90 .Walgreens Boots Alliance Inc was Resumed by BofA/Merrill to “Buy” on Jun 7, 2016.

Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.

Leave a Reply

Walgreens Boots Alliance Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Walgreens Boots Alliance Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.